As Lilly rivalry flares, Novo CEO sets out Wegovy launch strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
7 Themes to watch in 2024
February 4, 2024 2:00 PM ESTGoldman Sachs recently released its January update, presenting the "Top Themes" that their analysts believe investors should watch in 2024. Alongside this, the equity research firm made notable changes to its Conviction List, adding Parker Hannifan (NYSE: PH) and Textron (NYSE: TXT) while removing Bath & Body Works (NYSE: BBWI), Boeing (NYSE: BA), Shift4 Payments (NYSE: FOUR), and AIG (NYSE: AIG).
The Conviction List is Goldman Sachs' strategic approach to identifying... More
Novo Nordisk (NVO) gains as 2023 sales rise 31%
January 31, 2024 9:43 AM ESTNovo Nordisk (NYSE: NVO) shares gained more than 4% Wednesday after the company reported its latest quarterly and full-year 2023 earnings.
The company said sales increased by 31% in Danish kroner (DKK) to DKK 232.3 billion in 2023. Meanwhile, operating profit increased by 37% to DKK 102.6 billion.
"We... More
